We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Hematological Parameters Detect Patients with Acute VTE

By LabMedica International staff writers
Posted on 08 Oct 2019
Print article
Image: The Gen-S hematology analyzer (Photo courtesy of Beckman Coulter).
Image: The Gen-S hematology analyzer (Photo courtesy of Beckman Coulter).
Venous thromboembolism (VTE) encompasses deep venous thrombosis (DVT) and pulmonary embolism (PE). VTE causes cardiovascular death and disability and the risk of PE‐associated mortality and morbidity extends far beyond the acute phase of the disease.

Diagnosis of VTE is often difficult, and point score criteria help to estimate the clinical likelihood of DVT and PE. Patients with a low‐to‐moderate likelihood of DVT or PE should undergo initial diagnostic evaluation with D‐dimer testing alone without obligatory imaging tests; however, the D‐dimer assay is not specific.

Internal Medicine Scientists at Ziv Medical Center (Safed, Israel) and colleagues carried out a retrospective cohort study which aimed to examine the association and correlation between VTE and various new inflammatory markers taken from medical records of 272 patients admitted with VTE and 55 patients without VTE were used as control group.

Red blood cell distribution width (RDW), mean platelet volume (MPV), neutrophil‐lymphocyte ratio (NLR), and platelet‐lymphocyte ratio (PLR) were obtained and calculated from the complete blood count which executed in the hematology unit with Beckman Coulter Gen‐S system device. NLR was defined as the absolute neutrophil count divided by the absolute lymphocyte count. PLR was defined as the absolute platelet count divided by the absolute lymphocyte count. RDW and MPV were obtained from the results of the complete blood count (CBC).

The team reported that patients with VTE were older than controls (62 ± 18.9 versus 55.4 ± 15.1 years), respectively and female gender was predominant in the two groups. In the study group, 178/272 (66%) had DVT, 84/272 (31%) had pulmonary embolism (PE), and the rest had DVT and PE. NLR, MPV, and PLR were found to be significantly elevated in acute VTE compared to control. A ROC curve analysis of NLR and MPV for predicting acute VTE was performed, which found a cut‐off value of 5.3 for NLR, an area under curve of (0.67 [0.60‐0.75]), with a sensitivity of 69% and specificity of 57%, and a cut‐off value of 8.6 for MPV, an area under curve of (0.61 [0.53‐0.68]), with a sensitivity of 52% and specificity of 67%.

The authors concluded that the neutrophil‐lymphocyte ratio and MPV could be beneficial predictors for the early detection of potential acute VTE. The study was published on September 11, 2019, in the Journal of Clinical Laboratory Analysis.

Related Links:
Ziv Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.